| Quirk, Robin (Locate Therapeutics Ltd 201412 Executive Director) |
Chief Executive Officer (CEO) |
Locate Bio Ltd. |
United Kingdom (GB) |
| Raab, Martin (Endress+Hauser 201604 Head Public + Internal Communication) |
Public Relations Manager / Investor Relations Manager |
Endress+Hauser (Group) |
Switzerland |
| Rabbe, Anders (Isofol Medical AB 201502 Managing Director) |
Managing Director |
Isofol Medical AB |
Sweden |
| Rabini, Johannes (Sobera Capital 2010– Managing Director + Co-Founder before Triginta Capital) |
Managing Director |
Sobera Capital GmbH |
Germany |
| Rabinowitz, Matthew (Natera Inc 201302 CEO) |
Chief Executive Officer (CEO) |
Natera Inc. (Nasdaq: NTRA) |
United States (USA) |
| Rabus, Werner W. |
n. a. |
Eisenführ Speiser Patentanwälte Rechtsanwälte PartGmbB |
Germany |
| Rachel, Thomas (BMBF 200709 Staatssekretär) |
n. a. |
Germany (govt) |
Germany |
| Radakovic, Stojan (Ako med d.o.o. 201310 Director) |
President/Director/Head Business Group/Unit/Division |
Ako med d.o.o. |
Serbia |
| Radic, Christofer (Nanohale 201111 IR + PR Manager) |
Public Relations Manager / Investor Relations Manager |
Formycon (Group) |
Germany |
| Raditsch, Martin (Univ Frankfurt 202003 CEO of Innovectis) |
Chief Executive Officer (CEO) |
University of Frankfurt (Goethe-Universität) |
Germany |
| Radvanyi, Laszlo (Merck (DE) 201511– Head of Global Immuno-oncology Research before CSO at Lion Biotechnologies) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Merck (DE) (Group) |
Germany |
| Raem, Arnold Maria (Arrows Biomedical Deutschland GmbH 201408 Managing Director) |
Managing Director |
Arrows Biomedical (Group) |
Germany |
| Raetzman, Stuart (Alcon 201101 VP Global Marketing + General Manager US Business) |
Sales Manager / Marketing Manager |
Novartis (Group) |
Switzerland |
| Raffensperger, Alan (Sobi 201201– COO before Benechill + Amgen + Roche + Boehringer Mannheim + Pharmacia) |
Chief Operating Officer (COO) |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Rafigh, Mehran (Sartorius 201309 Business Development Manager before HTGF Investment Manager) |
Business Development Manager / Strategy Manager |
Sartorius (Group) |
Germany |
| Ragab, Mohamed (iTeos Therapeutics 201706– VP Corp Development before BMS + Roche + Pfizer + Ortho Biotech) |
Business Development Manager / Strategy Manager |
iTeos Therapeutics (Group) |
Belgium |
| Ragan, Paula (X4 Pharmaceuticals 201811 CEO) |
Chief Executive Officer (CEO) |
X4 Pharmaceuticals (Group) |
United States (USA) |
| Ragotzky, Klaus (Fidura 202011 Managing Director + Chairman of Advisory Board) |
Managing Director |
Fidura Private Equity Fonds (Group) |
Germany |
| Rajathurai, Arnold (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
| Rajewsky, Klaus (Harvard Univ 2002– before Univ Cologne) |
n. a. |
Harvard University |
United States (USA) |
| Rajmann, Britta |
n. a. |
Wiley (Group) |
Germany |
| Ralser, Markus (Francis Crick Institute 201606 before Univ Cambridge 201310) |
mass spectrometry (MS) |
Francis Crick Institute Ltd., The |
United Kingdom (GB) |
| Ramachandra, Murah (Aurigene 201306 SVP Preclinical Biology) |
Research & Development Manager |
Dr. Reddy’s (Group) |
India |
| Raman, Prakash (Flagship Pioneering 201911– Senior Partner + Chief BusDev Officer before Novartis NIBR + AstraZeneca) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
| Ramaswamy, Vivek (Roivant Sciences 201708 CEO + Founder) |
Chief Executive Officer (CEO) |
Roivant (Group) |
Switzerland |
| Rambeaux, Eric (MyoPowers 210506 CEO) |
Chief Executive Officer (CEO) |
MyoPowers Medical Technologies France S.A.S. |
France |
| Ramdahl, Thomas (Algeta 201308– COO before CTO before CEO since 2001) |
Chief Operating Officer (COO) |
Bayer (Group) |
Norway |
| Ramesh, R. (Medi Analytika India 201505 Managing Director) |
Managing Director |
Medi Analytika India Pvt. Ltd. |
India |
| Rampf, Stefan (Rentschler 201605–2020006 CFO before ABL Technik Entlackung GmbH + Volvo Financial Services LEFT 6/20) |
Chief Financial Officer (CFO) |
Rentschler (Group) |
Germany |
| Ramroth, Michael (Biotest 201301 CFO) |
Chief Financial Officer (CFO) |
Creat (Group) |
Germany |
| Ramsay, John (Syngenta 200707– CFO) |
Chief Financial Officer (CFO) |
Syngenta (Group) |
Switzerland |
| Rando, Jason (Tiberend Strategic Advisors 201707 EVP + COO) |
Chief Operating Officer (COO) |
Tiberend Strategic Advisors (NY) |
United States (USA) |
| Rang, Harald (BASF 201707 SVP Global RnD Crop Protection) |
Research & Development Manager |
BASF (Group) |
Germany |
| Rant, Ulrich (Dynamic Biosensors GmbH 201301 Managing Director (CEO) + Founder) |
Managing Director |
Dynamic Biosensors (Group) |
Germany |
| Rao, Venkat (Sartorius 201902 Head Business Management, EMEA Life Science Research) |
Business Development Manager / Strategy Manager |
Sartorius (Group) |
Germany |
| Rapp, Stephan (Neuway Pharma GmbH 20140–201508 Managing Director) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Rapp, Ulf R. (Universität Würzburg 200504) |
n. a. |
University of Würzburg |
Germany |
| Raquet, Line Stigen (Creoptix 202001– CEO before Mettler-Toledo + Qiagen) |
Chief Executive Officer (CEO) |
Creoptix AG |
Switzerland |
| Rasche, Michael (AstraZeneca 201707– promoted CCO at Definiens joined 201602 as SVP Global Sales before Ayoxxa + Dako) |
Chief Commercial Officer (CCO) |
AstraZeneca (Group) |
Germany |
| Rasche, Thom (Earlybird 200809 Partner) |
Partner (venture partner) |
Earlybird (Group) |
Germany |
| Rascher-Eggstein, Gesa (Nanion Technologies 201607– Marketing Director before Anaxon + Axiogenesis + Cytocentrics) |
n. a. |
Nanion (Group) |
Germany |
| Raschke, Eva |
n. a. |
Thermo Fisher (Group) |
Germany |
| Raschke, Fabian (Grünenthal 201902– CFO joined 201609 before Xella Group) |
Chief Financial Officer (CFO) |
Grünenthal (Group) |
Germany |
| Rasi, Guido (EMA 201111– Executive Director) |
Administrative Officer (personnel) |
EU (govt) |
Netherlands |
| Rasmus, Conrad (Protembis GmbH 2013– Managing Director + Co-Founder) |
Managing Director |
Protembis GmbH |
Germany |
| Rataj, Sue H. (Agilent 201509– Non-exec Board Member + Bayer 201204– Supervisory Board Member before BP retired 4/11) |
Board member, non-executive |
Agilent (Group) |
United States (USA) |
| Ratcliffe, Andrew (Cellzome 200809– Director Chemistry before UCB Celltech) |
n. a. |
GlaxoSmithKline (GSK) (Group) |
United States (USA) |
| Ratcliffe, Ian (Stemgent 201303 CEO) |
Chief Executive Officer (CEO) |
ReproCell (Group) |
United States (USA) |
| Rathgeb, Frank (Sygnis Pharma 201109 CMO) |
Chief Medical Officer (CMO) |
Expedeon (Group) |
Germany |
| Rathi, V. L. (Advanced Enzyme Technologies 201707 Chairman) |
Board member |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
India |
| Rathmann, Torsten (Werner Rathmann Maschinenbau GmbH 201106 Managing Director) |
Managing Director |
Werner Rathmann Maschinenbau GmbH |
Germany |
| Raths, Jürgen (Paion 201509–201703 COO before Executive Insight + Correvio Intl + Arpida + Lilly LEFT 3/17) |
Chief Operating Officer (COO) |
Paion (Group) |
Germany |
| Rauch, Jörg (Univ Heidelberg 201404 Managing Partner of Technology Transfer Heidelberg GmbH) |
Managing Director |
University of Heidelberg (Ruperto Carola) |
Germany |
| Rauch, Peter (Candor Bioscience 201310 Managing Director) |
Managing Director |
Candor Bioscience GmbH |
Germany |
| Raue, Jan Simon (Fosanis GmbH 201908 Managing Director + Co-Founder) |
Managing Director |
Fosanis GmbH |
Germany |
| Raueiser, Thomas (Nordrhein-Westfalen (govt) 201106 Investment Manager at NRW.BANK) |
Investment Manager |
Nordrhein-Westfalen (govt region) |
Germany |
| Rauen, Hans-Werner (Bayer 201501 Global Regulatory Affairs Manager Insecticides at Bayer CropScience) |
Regulatory Affairs Manager |
Bayer (Group) |
Germany |
| Raupach, Georg (Bayer 201501 Global Product Manager Insecticides at Bayer CropScience) |
Product Manager (personnel) |
Bayer (Group) |
Germany |
| Raupach, Stefan (Abviris 2014– Managing Director + Co-Founder) |
Managing Director |
Abviris Deutschland GmbH |
Germany |
| Rausch, Oliver (Storm Therapeutics 201702 VP R&D before Cellzome + UCB Celltech + GSK) |
Research & Development Manager |
Storm Therapeutics Ltd. |
United Kingdom (GB) |
| Rausch, Sebastian (Berlin Capital Fund 200504 Senior Investment Manager) |
Investment Manager |
Triginta Capital (Group) |
Germany |
| Rauschenbusch, Alex (Grazia Equity GmbH 201412 Managing Partner) |
Managing Partner (investment firm) |
Grazia Equity GmbH |
Germany |
| Rautter, Joachim (Peppermint 2014 Managing Partner) |
Managing Partner |
Peppermint (Group) |
Germany |
| Ravagnan, Luca (Wise Srl 202010 CEO) |
Chief Executive Officer (CEO) |
Wise (Group) |
Italy |
| Ravishankar, Hema (Evonik 200806 Business Director Pharma Polymer India) |
Business Development Manager / Strategy Manager |
Evonik (Group) |
Germany |
| Ravnsborg, Christian (Bruker 201606 Director Market Solutions at Bruker Daltonics) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Raya, Michael (Hikma 201507 Managing Director of West-Ward) |
Managing Director |
Hikma (Group) |
United States (USA) |
| Rayment, Cary (Alcon –200709– President, Chairman + CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Raymont, Michael (AVAC Ltd 201502 CEO) |
Chief Executive Officer (CEO) |
AVAC Ltd. |
Canada |
| Rebeaud, Fabien (Abionic 201909 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Abionic S.A. |
Switzerland |
| Reckmann, Bernd (Merck KGaA 1986–201604 Executive Board Member since 2007 RETIRED 4/16)) |
Board member, executive |
Merck (DE) (Group) |
Germany |
| Reddy, David (Roche 200611 Influenza Pandemic Taksforce Leader) |
n. a. |
Roche (Group) |
Switzerland |
| Redfern, David (GSK 201508 Chief Strategy Officer) |
Corporate Strategy Manager |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Reed, John C. (Sanofi 201807– Global Head RnD before Roche 2013–201804 Head of pRED LEFT) |
President/Director/Head Business Group/Unit/Division |
Sanofi (Group) [since May 2011] |
France |
| Reeder, Kevin (Thuringia (govt) 201808 CEO of bm|t) |
Chief Executive Officer (CEO) |
Thuringia (govt region) |
Germany |
| Reeks, Toby (SGS 202012 SVP Investor Relations + Corporate Communciations + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Rees, Steve (AstraZeneca 201712 VP Discovery Biology) |
n. a. |
AstraZeneca (Group) |
United Kingdom (GB) |
| Reessink, Michiel (UgenTec 202102 VP of Global Sales) |
Sales Manager / Marketing Manager |
UgenTec N.V. |
Belgium |
| Regan, Brian (WCAS 201707 General Partner) |
General Partner (venture partner) |
Welsh, Carson, Anderson & Stowe (WCAS) |
United States (USA) |
| Regev, Aviv (Roche 202008– Head of gRED before Broad Institute + Thermo Fisher SAB Member) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Regnery, Andreas (Belyntic GmbH 201909 Co-Founder) |
Company Founder |
Belyntic GmbH |
Germany |
| Rehlen, Karen-Elise (Eric Salmon & Partners 201305– Life Sciences Consultant in Frankfurt before AT Kearney) |
Human Resources Manager |
Eric Salmon & Partners (Group) |
Germany |
| Rehmann, Wolfgang (Taylor Wessing 201510 München + Head Life Sciences) |
Attorney / Lawyer |
Taylor Wessing (Group) |
Germany |
| Reich, Jens |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Reich, Ronald (NovaPump GmbH 201307 Managing Director + JTI) |
Managing Director |
NovaPump GmbH |
Germany |
| Reichel, Matthias |
n. a. |
Leibniz-Gemeinschaft |
|
| Reichert, Jörg (Seltenerden Storkwitz 201403 CEO) |
Chief Executive Officer (CEO) |
Seltenerden Storkwitz AG (SES) |
Germany |
| Reichl, Manfred (Apeiron 201710 Supervisory Board Chairman) |
Supervisory Board Member |
Apeiron (Group) |
Austria |
| Reichstein, Irmgard (Axel Semrau 201307 Head Marketing) |
Sales Manager / Marketing Manager |
Axel Semrau GmbH & Co.KG |
Germany |
| Reichwein, Jörg (Atto-Tec 200506 Managing Director) |
Managing Director |
Atto-Tec GmbH |
Germany |
| Reicin, Alise (Tectonic Therapeutic 202010 CEO before Merck (DE) 201505– Head Global Clinical Development before MSD) |
Clinical Research Manager |
Tectonic Therapeutic Inc. |
United States (USA) |
| Reid-Anderson, James W. P. (Jim) (Siemens 200711– CEO before Dade Behring President + CEO before CFO since 1996) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Reif, Oscar-Werner (Sartorius 200905 Director R&D) |
Research & Development Manager |
Sartorius (Group) |
Germany |
| Reim, Wolfgang (BB Medtech 200705– Verwaltungsrat) |
n. a. |
Bellevue (Group) |
Switzerland |
| Reimann, Andreas (Agilent Technologes Sales & Services GmbH & Co. KG 200706) |
n. a. |
Agilent (Group) |
Germany |
| Reimann, Thomas (Eppendorf 201709 Managing Director at Eppendorf Polmyere GmbH) |
Managing Director |
Eppendorf (Group) |
Germany |
| Reimer, Andreas (Contagi Personal 201911 Partner Global Life Sciences) |
Human Resources Manager |
Contagi (Group) |
Germany |
| Reimold, Malte (Gerstel 201204 Marketing Specialist) |
Sales Manager / Marketing Manager |
Gerstel (Group) |
Germany |
| Reindl, Max (Wavelight CEO + Founder) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Germany |
| Reine, Allan (Foghorn Therapeutics 201909– CFO before Pieris + Lombard Odier Asset Management + CIBC World Markets) |
Chief Financial Officer (CFO) |
Foghorn Therapeutics Inc. |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 51 52 53 ... 73 74 75 
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
